How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Hong Kong billionaire puts quarter of his wealth in gold
Rianlon’s RM1.27bil project boosts Johor’s high-value manufacturing push
Opensys wins RM22mil cash recycling machines supply contract
Reservoir Link secures its first CCS solutions contract
PETRONAS appoints Mohd Jukris as COO effective Feb 1, 2026
FBM KLCI ends flat ahead of Bank Negara policy meeting
Oil down as easing Iran unrest dampens geopolitical risk premium
CIMB boosts customer protection with new biometric authentication in Octo App
IJM tumbles 5%, short selling suspended amid MACC probe
China set to keep rates steady for eighth month, some traders wager on Q1 easing

Others Also Read